Glycopyrrolate Injection
Product Images NDC 71872-7013

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7013). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7013-1 Pdp (71872 7013 1 Pdp)

71872-7013-1 Pdp (71872 7013 1 Pdp)
This is a description of Glycopyrrolate Injection, USP, a medication that comes in a 20mL vial with a concentration of 0.2 mg/mL, with each vial containing 4mg of the medication. It can be administered via intramuscular or intravenous routes and contains benzyl alcohol. It should not be used in newborns. The solution is made with water for injection, USP, and contains 0.6% benzyl alcohol as a preservative. The usual dosage can be found in the package insert, and it should be stored between 20-25°C (68-77°F). The medication is distributed by West-Ward in the USA and its Manufacturer NOC is 00143.9676-10.*
FDA Label Image

Chemical Structure (Glycopyrrolate Injection 1)

Chemical Structure (Glycopyrrolate Injection 1)
The text refers to a chemical compound with the formula CisHBrNOs and a molecular weight of 39833. There is not much additional information available to provide a more detailed description.*
FDA Label Image

Layout 1 (Glycopyrrolate Injection 10)

Layout 1 (Glycopyrrolate Injection 10)
This is a product identification label or packaging with a GTIN (Global Trade Item Number) of 0301234567896, a serial number (SN) of 1234567890123, an expiration date (EXP) of MMMYYYY and a lot number (LOT) of ABCDE12345.*
FDA Label Image

Pdp (Glycopyrrolate Injection 8)

Pdp (Glycopyrrolate Injection 8)
Beonly Glycopyrrolate Injection is used intravenously or intramuscularly, but not for newborns. It is supplied in a 20 mL vial with 4 mg/20 mL of glycopyrrolate (0.2 mg/mL) and contains benzyl alcohol as a preservative. The pH is adjusted with hydrochloric acid and sodium hydroxide when necessary. It should be stored between 20° to 25°C (68” to 77°F) [See USP Controlled Room Temperature]. The usual dosage should be checked in the package insert. The product is distributed by WEST-WARD in Eatonton, NJ 07724 USA. The Lot and Exp numbers are unreadable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.